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Abstract: The case of a 14-year-old mongrel dog with a thyroid tumor treated by thyreoidectomy is described. 
The resected tumor was subjected to a detailed morphological and immunohistochemical analysis utilizing anti-
bodies directed against thyroglobulin, calcitonin, chromogranin A, cytokeratin 19, thyroid transcription factor-1, 
CD31, Ki-67 and minichromosome maintenance protein 3. Expression level of the abovementioned antigens 
allowed to characterize the resected tumor as thyroid follicular-compact carcinoma. Common application of 
immunohistochemistry may increase the diagnosis precision and efficacy of thyroid tumor treatment in dogs. 
(Folia Histochemica et Cytobiologica 2014, Vol. 52, No. 2, 157–161)
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Introduction
Canine thyroid tumors account from 1% to 3% of all 
neoplasias in the species and mostly involve a single 
lobe [1]. Morphological traits of the tumors allow to 
distinguish well-differentiated, poorly-differentiated 
and undifferentiated (seldom seen) thyroid carci-
nomas. The well-differentiated malignant tumors 
include follicular carcinomas with an evident follicular 
structure and more or less solid cellular structure (fol-
licular-compact cellular carcinoma, compact cellular 
carcinoma), and medullary carcinomas developing 
from parafollicular C cells [2, 3]. Precise diagnosis 
of a tumor in some circumstances requires ancillary 
methods to the routine hematoxylin and eosin (H&E) 
staining. Therefore,  immunohistochemical techniqu-
es must be often additionally implemented to make 
the final diagnosis. Immunohistochemistry (IHC) is 
not only useful for confirmation of the preliminary 
diagnosis of canine thyroid tumors, but it also allows 
to predict prognosis. Regrettably, respective scien-
tific reports on the subject remain relatively scanty 
as in veterinarian practice IHC does not belong to 
the routinely performed techniques. In the current 
report the isolated tumor was subjected to an accurate 
morphological and IHC analysis. The obtained deta-
iled characteristics enriched the currently restricted 
knowledge on the application of various markers in 
diagnosis of canine thyroid tumors.
Clinical examination and handling
The 14-year-old mongrel dog with transplacable 
tumor of the neck was referred to the Veterinarian 
Outpatient Clinic of the Department of Surgery. 
The trachea manifested tenderness upon physical 
examination. Ultrasound examination demonstrated 
a non-uniform, well separated and blood supplied 
158 Rafal Ciaputa et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2014
10.5603/FHC.2014.0009
www.fhc.viamedica.pl
tumor in projection of the left thyroid lobe, around 
4.5 × 3.5 × 3.5 cm in size. No lymphadenopathy was 
observed in surrounding cervical tissues. In the chest 
X-ray no pulmonary lesion suspicious of metastases 
were found.
Thyroidectomy confirmed the presence of an oval 
tumor, separated from vicinity by a thin capsule. The 
organ was removed in toto and transferred to the 
Department of Pathology (Figure 1A). Cross-section 
of the tumor disclosed centrally located focus of ne-
crosis (Figure 1B). Due to the absence of pulmonary 
metastases or infiltration of the surrounding tissues 
the prognosis was defined as favourable. 
Diagnostic procedure
The excised tumor was examined on H&E- and IHC- 
-stained paraffin sections. Immunohistochemistry 
was performed utilizing following murine anti-human 
monoclonal antibodies (at respective concentrations 
applied for 1 h at room temperature) directed aga-
inst following antigens: cytokeratin 19 (CK-19; clone 
RCK108; 1:100), thyroid transcription factor (TTF-1; 
clone 8G7G3/1; 1:100), Ki-67 antigen (clone MIB-1; 
1:100), minichromosome maintenance protein 3 
(MCM3; clone 101; 1:50, Novocastra, Newcastle, UK), 
CD31 (clone JC70A; 1:100), thyroglobulin (Tg; clone 
DAK-Tg6; 1:100) and chromogranin A (clone DAK-
-A3; 1:100). For calcitonin detection polyclonal rabbit 
anti-human antibody (1:400) was used.  The studied 
antigens were visualized using secondary biotinylated 
antibodies and streptavidin-biotinylated peroxidase 
complex (LSAB2, HRP) according to the manufactu-
rer’s instructions. The 3,3’-diaminobenzidine (DAB; 
for 7 min, room temperature) was used as a substrate 
for the reaction. All the sections were counterstained 
with Meyer’s hematoxylin. All the reagents and antibo-
dies (except the MCM3 antibody) were obtained from 
DakoCytomation (Glostrup, Denmark).
Diagnosis
Histological evaluation of H&E-stained sections 
demonstrated a fully obliterated organ structure 
with regions of neoplastic hyperplasia. The majority 
of the tumor was composed of solid bands of tumor 
cells with large irregular in shape nuclei, containing 
granular chromatin. The bands were separated from 
Figure 1. Mongrel dog with thyroid tumor. A. Transplacable tumor of the cervical regio. B. Intraoperative view. C. Macro-




©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2014
10.5603/FHC.2014.0009
www.fhc.viamedica.pl
each other by fibrous septa of a variable thickness, 
containing thin-wall blood vessels. Occasionally, 
individual, small colloid-filled vesicles were encoun-
tered (Figure 2A). The neoplastic cells were found to 
infiltrate and damage the walls of blood vessels (Fig-
ure 2B) as well as interruption of tumor capsule was 
observed (Figure 2C). In several parts of the tumor 
haemorrhagic foci and necrotic regions of various size 
were observed (Figure 2D).
The IHC examination disclosed variable levels of 
expression of examined markers. A definitely highest 
expression level was noted in cases of thyroglobulin, 
cytokeratin-19 (both cytoplasmic localization), while 
a lower nuclear TTF-1, Ki-67 (32% of positive cells) 
and MCM3 (35% of positive cells) expression level 
was demonstrated (Figure 3). No expression of calci-
tonin or chromogranin A was noted in the tumor cells. 
Using the anti-CD31 antibody, infiltration of adjacent 
vessels by tumor cells observed in H&E-slides was 
confirmed (Figure 3).
The histopathological and IHC patterns allowed to 
diagnose a thyroid carcinoma of a vesicular-compact 
type. Adenoma, medullary carcinoma, mixed vesiculo-
medullary thyroid carcinoma, carotid body tumor, 
soft-tissue sarcoma and haemangiopericytoma were 
taken into consideration in the differential diagnosis 
of the above described tumor.
Discussion
Thyroid tumors in dogs account for around 10–15% 
of all neoplasias within the head and neck region, and 
90% of them are diagnosed as carcinomas. Already 
at the moment of diagnosis 16% to 38% patients 
carry visible metastases. Although no sex prevalence 
was detected, age-related (10 to 15 years of age) and 
breed-linked (Beagles, Golden retriever, Syberian 
husky) predispositions were documented [4, 5]. In 
dogs an extensive practical significance is linked to 
clinical evaluation of a tumor according to guidelines 
Figure 2. Dog, thyroid tumor, H&E staining. A. Region with a compact structure of undifferentiated cells with preserved 
individual normal vesicles. B. Blood vessel infiltrated by neoplastic cells. C. Interruption of tumor capsule. D. Dissolving 
necrotic masses of neoplastic thyroid cells 
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of World Health Organization (WHO) (involving i.a., 
tumor size, transplacebility) what provides basis for 
selection of the most accurate therapeutic manage-
ment [1]. In cases of skin-transplacable cancers thyro-
idectomy represents the approach of choice. However, 
upon detection of extensive tumors which infiltrate 
surrounding tissues external beam therapy or radio-
active iodine-131 (131I) therapy are recommended [4]. 
Histological evaluation of canine tumor types seems 
to be easier than in humans due to lower variability of 
forms demonstrated by the lesions [2]. Nevertheless, 
IHC evaluation is indispensable for establishment of 
a proper diagnosis of the tumor subtype. Such tests are 
crucial in confirmation of thyroid origin of carcinomas 
developing in the head and neck region in cats or dogs 
[6–8]. It is worth to mention that introduction of IHC 
techniques into diagnosis of canine thyroid tumors 
resulted in an increasing frequency of medullary 
Figure 3. Expression of selected markers in canine thyroid 
neoplastic cells. High expression of cytokeratin-19 (A),  
Ki-67 (B), TTF-1 (C), thyroglobulin (D), MCM-3 (E)  
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carcinoma diagnoses, earlier thought to represent a 
very rare neoplasia [8]. Lines of evidence suggest that 
application of calcitonin, thyroglobulin, TTF-1 and 
chromogranin A as IHC markers is useful in differential 
diagnosis of canine thyroid lesions [8–10]. In this report, 
the set of markers has been supplemented with CK-19, 
Ki-67 antigen and MCM3 protein. CK-19, in line with 
galectin-3, Ret oncoprotein, HBME-1 may be useful in 
distinguishing malignant from benign lesions since in 
human carcinomas the reaction product is pronounced 
and localized in a diffuse manner. First of all, CK-19 is 
a useful marker in confirmation of epithelial origin of 
the tumor [11]. The extent of immunostaining is higher 
in papillary carcinoma, however CK-19 is present in 
all cases of follicular carcinoma at least focally [12]. 
The high mitotic potential of the analyzed tumor was 
confirmed by the high expression of Ki-67 antigen in 
cancer cells. Moreover, a pronounced expression of 
MCM3 in tumor cells (comparable to that of the Ki-67 
antigen) was demonstrated. In some studies MCM3 
was shown, to be an useful marker for determination of 
cell proliferative potential in canine tumors of various 
histological types [13]. The CD31 staining confirmed 
the observed infitration of tumor capsule by cancer 
cells, as the latter were also observed in lumen of the 
CD31-positive vessels. The studied canine thyroid car-
cinomas has manifested a selective reactivity with the 
applied antibodies. The selectivity has corresponded 
to cellular structure of the tumor, typical for thyroid 
carcinomas of a vesicular origin. The negative results 
of IHC directed towards detection of chromogranin 
A and calcitonin have been expected since the com-
pounds represent markers of medullary carcinomas 
(originating from C cells) [8, 9, 14]. The accurate dia-
gnosis of carcinoma type in dogs may be of prognostic 
significance since medullary carcinomas in these 
animals used to be well encapsulated, less invasive 
and manifest lower tendency to develop metastases 
as compared to vesicular carcinomas [8]. Apart from 
assistance in stratifying the prognosis, an accurate 
diagnosis of canine thyroid carcinoma type might 
prove usefulness in therapy, similarly to the situation 
seen in humans. In studies of Liptak et al. therapy 
with radioactive iodine yielded encouraging results in 
dogs subjected earlier to thyroidectomy (mean survi-
val 30–34 months) [1]. However, the authors did not 
mention whether the removed carcinomas were sub-
jected to an accurate classification of types. It might be 
expected that tumor positively reacting to such a treat-
ment represented follicular carcinomas since only 
follicular cells are capable of iodine absorption [14]. 
In cases of medullary carcinomas, originating from 
iodine not absorbing parafollicular cells, such 
a treatment would be pointless.
Conclusion
The presented case report aimed at presenting the 
potential utility of immunohistochemistry in the 
diagnosis of a thyroid tumor in dog. The selected 
panel of antibodies allowed for a precise diagnosis of 
a follicular-compact carcinoma. Precise identification 
of the type of cancer can increase the effectiveness 
of the treatment and yield prognostic significance.
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